期刊文献+

他克莫司软膏治疗46例面部复发性皮炎疗效观察 被引量:6

下载PDF
导出
摘要 面部复发性皮炎病因复杂,病情反复发作,很多患者常外用糖皮质激素,长期应用可导致多种不良反应。他克莫司是非糖皮质激素类外用免疫调节剂,具抗炎止痒作用,已成功用于银屑病、特应性皮炎等炎症性皮肤病的治疗,尤其是在头面部特殊部位的应用得到好评㈣。笔者于2008年7月-2009年12月采用他克莫司软膏治疗面部复发性皮炎患者46例,结果报告如下。
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2011年第11期704-705,共2页 Journal of Clinical Dermatology
  • 相关文献

参考文献3

二级参考文献9

  • 1Paller A,Eichenfield LF,Leung DY,et al.A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients[J].J Am Acad Dermatol, 2001,44(1):47-57.
  • 2Leung DY,Boguniewicz M, Howell MD,et al.New insights into atopic dermatitis[J].J Clin Invest, 2004,113(5):651-675.
  • 3Charman C,Morris AD,Williams HC.Topical corticosteroid phobia in patients with atopic dermatitis[J]. Br J Dermatol,2000,142:931-936.
  • 4Kang S, Lucky AW, Pariser D,et al.Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children[J].J Am Acad Dermatol,2001,44(1l):58-64.
  • 5Simon D,Vassina E,Braathen LR,et al.Immunopharmacological effects of topical tacrolimus in atopic dermatitis[J].J Allergy Clin Immunol,2004,113(2):S334.
  • 6Beck LA.The efficacy and safety of tacrolimus ointment:a clinical review[J].J Am Acad Dermatol,2005,53 (2 Suppl 2):S165-S170.
  • 7Freeman AK,Serle J,VanVeldhuisen P,et al.Tacrolimus ointment in the treatment of eyelid dermatitis[J].Cutis,2004,73(4):267-271.
  • 8Hengge UR,Ruzicka T,Schwartz RA,et al.Adverse effects of topical glucocorticosteroids[J].J Am Acad Dermatol,2006,54(1):1-15.
  • 9Kyllonen H,Remitz A,Mandelin JM,et al.Effects of 1-year intermittent treatment with topical tacrolimus monotherapy on skin collagen synthesis in patients with atopic dermatitis[J].Br J Dermatol,2004,150(6):1174-1181.

共引文献128

同被引文献30

  • 1王秀兰.0.03%他克莫司软膏联合依巴斯汀治疗颜面再发性皮炎50例疗效观察[J].浙江医学教育,2012,11(5):59-60. 被引量:2
  • 2刘玲玲,窦侠,闻卫兢,郑志忠,王宝玺,林麟,曾凡钦,顾军,朱学骏.他克莫司软膏治疗成人特应性皮炎疗效和安全性研究[J].中华皮肤科杂志,2005,38(7):406-409. 被引量:29
  • 3《中国医学百科全书》编辑委员会.维吾尔医学[M].上海:上海科学技术出版社,2005.9.
  • 4Kang KI, Meng X, Devin-lecerc J, et al. The molecular chaperone Hsp90 can negatively regulate the activity of a glucocorti-costeroid-dependent promoter [J]. Proc Nat Acad Sci USA, 1999,96(4) : 1439-1444.
  • 5Qian X,Zhu Y,Xu W, et al . Glucocorticoid receptor and heat shock protein 90 in peripheral blood mononuclear cells from asthmatics[J]. Chin Med J (Engl), 2001,114(14) : 1051-1054.
  • 6Hanifin JM. Ling MR, Langley R , et al . Tacrdimus oimtment for the treatment of atopie dermatitis in adult patients : part Ⅰ,efficaey[J]. J Am Acad Dematol , 2001,44(1 suppl) : S28- S38.
  • 7Soter NA , Fleischer AB Jr, Webster GF , et al . Taerolimus ointment for the treatment of atopic dermatitis in adult patients : part Ⅱ, safety[J] . J Am Acad Dermatol, 2001,44 (1 Suppl) : S39-S46.
  • 8Olhnberg A, Sharma S, von Bubnoff D, et al. Topical tacrolimas(FK505) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis [J]. AUergy Clin Immunol, 2001,107 (3) : 519-529.
  • 9Wollenberg A,Sharma S,von Bubnoff D,et a丨.Topical tacrolimas(FK506) leads to profound phenotypic and functional alterationsof epidermal antigen.presenting dendritic cells in atopic der-matitis[J].J Allergy Clin Inmunol,2001,107(3):519-529.
  • 10Mulekar SV, Issa AA, Eisa AA. Treatment of halo nevus with a308- nm excimerlaser: a pilot study [ J ]. Cosmet Laser Ther,2007,9 (4) : 245 -248.

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部